Search results
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 2 days agoTwo other RSV vaccines, Arexvy from GlaxoSmithKline (GSK) and Abrysvo from Pfizer, received FDA...
AbbVie's tight grip on Humira market raises concerns about biosimilars
Reuters via AOL· 5 hours agoAbbVie’s top-selling arthritis drug Humira has held onto more than 80% of patients after facing nine...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
TV 7&4 Traverse City· 1 day agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
Zacks via Yahoo Finance· 24 hours agoThe late-stage study will evaluate AbbVie's (ABBV) experimental antibody to treat patients with...
FDA Advisers Recommend Omicron-Focused COVID Boosters for Fall
Homenewshere.com· 22 hours agoFDA advisers recommended that the new COVID-19 boosters for fall target the Omicron variant, which...
GSK shares fall 9% in wake of Zantac court ruling
Pharmaceutical Technology via Yahoo Finance· 3 days agoPfizer, Boehringer Ingelheim, Sanofi, and Patheon are also implicated in the cases. In 2020, the US Food and Drug Administration (FDA) ordered the...
Will there be a new Covid vaccine in the fall?
NBC Universal via AOL· 2 days agohe added. The FDA is expected to make a final decision soon on which strain it will advise drugmakers to target. That will kickstart production of the...
Novavax, With A 369% Gain, Tears Ahead Again On A Key FDA Move
Investor's Business Daily· 1 day agoIn a filing with the Securities and Exchange Commission, Novavax said the FDA said it completed its...
Chutes & Ladders—Sanofi research head Frank Nestle says au revoir
FierceBiotech· 3 hours agoPlease send the good word—or the bad—from your shop to Gabrielle Masson and it will be featured here...
FDA advisers: Target JN.1 strain in fall’s COVID vaccine
The Columbian· 1 day agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
